Overview

Plenful specializes in automating pharmacy operations workflows to improve efficiency in healthcare settings. Its main product is a software-as-a-service (SaaS) platform that integrates with existing systems like Electronic Health Records (EHRs) and Pharmacy Management Systems (PMSs). The platform uses AI and rules-based data centralization to streamline manual tasks, making operations more efficient and accurate. Unlike many competitors, Plenful offers pre-configured workflows based on industry best practices and features proprietary Optical Character Recognition (OCR) technology, allowing for easy integration without the need for coding. The goal of Plenful is to relieve healthcare employees from repetitive tasks, optimize staffing, and enhance transparency in pharmacy operations.

Simplify's Take

What believers are saying

• Plenful raised $50M in Series B funding to expand its AI platform.
• The healthcare automation market is projected to reach $88.9 billion by 2027.
• AI integration in healthcare could save the industry $150 billion annually by 2026.

What critics are saying

• Kyndryl's AI-powered workflow service poses a competitive threat to Plenful.
• Competitors like Notable and Infinitus are gaining traction in healthcare automation.
• Rapid AI advancements by competitors could challenge Plenful's market position.

What makes Plenful unique

• Plenful specializes in automating pharmacy operations workflows with AI-driven solutions.
• The platform integrates seamlessly with EHRs and PMSs, enhancing data centralization.
• Plenful offers zero-code integration capabilities, simplifying adoption for healthcare providers.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$76M

Above

Industry Average

Funded Over

3 Rounds

Notable Investors:

Bessemer Venture Partners

Notable Investors:

Bessemer Venture Partners

$50,000,000

Series B

May 2025

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Above Average

Industry standards

Ind Avg. $35M

$4M

$30M

$45M

$50M

$65M

$100M

View all funding stages